Yungjin Pharm. Co., Ltd.

ACTIVE

Rm 301 Hansin Bldg., Changwon, Gyeongnam, South Koreawww.yungjin.co.krPublic624 employeesEstablished: 1962-07-16

Also known as:

yungjin pharm. co., ltd._gyeongnam branch

yungjin pharm. co., ltd._chungcheong branch

yungjin pharm. co., ltd._gyeongbuk branch

yungjin pharm. co., ltd._gyeongwon branch

yungjin pharm. co., ltd._busan branch

yungjin pharm. co., ltd._north seoul branch

yungjin pharm. co., ltd._west seoul branch

yungjin pharm. co., ltd._jeonnam branch

Part of KT&G Corp.

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1962

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

58.3%

Phase 2

33.3%

Phase 4

8.3%

Trial Status Distribution

Completed

91.7%

Terminated

8.3%

Clinical Trials

Trials sponsored by this organization (12)

A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects

Phase 1

Completed

interventional

Jan 202188 participants

Evaluate the Pharmacokinetic Characteristics and Safety/Tolerability of YNP-1807 Compared to Lyrica® After Oral Administration Adult Volunteers

Phase 1

Completed

interventional

Sep 201717 participants

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

Phase 1

Completed

interventional

Jun 201760 participants

A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis

Phase 2

Completed

interventional

Apr 2017116 participants

A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients

Phase 2

Completed

interventional

Jun 201561 participants

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

Phase 1

Completed

interventional

Jan 201511 participants

A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis

Phase 4

Completed

interventional

Feb 2013182 participants

Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis

Phase 2

Terminated

interventional

Jan 201318 participants

Page 1 of 2

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

Recent Approvals

News

No news articles found

Back to Organizations